Skip to Main Content

Author Details

Petra Lenz
Frederick National Laboratory for Cancer Research
1996
35
20
PMIDPaper TitleJournal TitlePublished Year
36961501Evidence for virus-mediated oncogenesis in bladder cancers arising in solid organ transplant recipients.Elife2023
37210288Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights.Eur Urol2023
36961501Evidence for virus-mediated oncogenesis in bladder cancers arising in solid organ transplant recipients.Elife2023
37210288Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights.Eur Urol2023
34618413Characterizing the tumor microenvironment in rare renal cancer histological types.J Pathol Clin Res2022
34618413Characterizing the tumor microenvironment in rare renal cancer histological types.J Pathol Clin Res2022
34753492Mammary collagen architecture and its association with mammographic density and lesion severity among women undergoing image-guided breast biopsy.Breast Cancer Res2021
34493867Genomic and evolutionary classification of lung cancer in never smokers.Nat Genet2021
34753492Mammary collagen architecture and its association with mammographic density and lesion severity among women undergoing image-guided breast biopsy.Breast Cancer Res2021
34493867Genomic and evolutionary classification of lung cancer in never smokers.Nat Genet2021
31864026Diesel exhaust and bladder cancer risk by pathologic stage and grade subtypes.Environ Int2020
31864026Diesel exhaust and bladder cancer risk by pathologic stage and grade subtypes.Environ Int2020
30655088Differences in Tumor VHL Mutation and Hypoxia-inducible Factor 2α Expression Between African American and White Patients with Clear Cell Renal Cell Carcinoma.Eur Urol2019
30655088Differences in Tumor VHL Mutation and Hypoxia-inducible Factor 2α Expression Between African American and White Patients with Clear Cell Renal Cell Carcinoma.Eur Urol2019
29548022RE: Elevated Bladder Cancer in Northern New England: The Role of Drinking Water and Arsenic.J Natl Cancer Inst2018
29548022RE: Elevated Bladder Cancer in Northern New England: The Role of Drinking Water and Arsenic.J Natl Cancer Inst2018
27552842Relationships between mammographic density, tissue microvessel density, and breast biopsy diagnosis.Breast Cancer Res2016
27635065The Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial Pathology Tissue Resource.Cancer Epidemiol Biomarkers Prev2016
27552842Relationships between mammographic density, tissue microvessel density, and breast biopsy diagnosis.Breast Cancer Res2016
27635065The Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial Pathology Tissue Resource.Cancer Epidemiol Biomarkers Prev2016
26374428Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms.J Natl Cancer Inst2015
26374428Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms.J Natl Cancer Inst2015
25320178The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease.Cancer Res2014
25320178The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease.Cancer Res2014
23266392Genetic variant as a selection marker for anti-prostate stem cell antigen immunotherapy of bladder cancer.J Natl Cancer Inst2013
23266392Genetic variant as a selection marker for anti-prostate stem cell antigen immunotherapy of bladder cancer.J Natl Cancer Inst2013
22539607Correlation of LINE-1 methylation levels in patient-matched buffy coat, serum, buccal cell, and bladder tumor tissue DNA samples.Cancer Epidemiol Biomarkers Prev2012
22539607Correlation of LINE-1 methylation levels in patient-matched buffy coat, serum, buccal cell, and bladder tumor tissue DNA samples.Cancer Epidemiol Biomarkers Prev2012
22761304Cell-cycle control in urothelial carcinoma: large-scale tissue array analysis of tumor tissue from Maine and Vermont.Cancer Epidemiol Biomarkers Prev2012
23552698Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation.Oncogenesis2012
24683496Analysis of the Distribution and Temporal Trends of Grade and Stage in Urothelial Bladder Cancer in Northern New England from 1994 to 2004.ISRN Pathol2012
24683496Analysis of the Distribution and Temporal Trends of Grade and Stage in Urothelial Bladder Cancer in Northern New England from 1994 to 2004.ISRN Pathol2012
23552698Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation.Oncogenesis2012
22761304Cell-cycle control in urothelial carcinoma: large-scale tissue array analysis of tumor tissue from Maine and Vermont.Cancer Epidemiol Biomarkers Prev2012
21284444Observer variability in the interpretation of HER2/neu immunohistochemical expression with unaided and computer-aided digital microscopy.Arch Pathol Lab Med2011
21284444Observer variability in the interpretation of HER2/neu immunohistochemical expression with unaided and computer-aided digital microscopy.Arch Pathol Lab Med2011
22022277Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factors.PLoS Genet2011
22022277Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factors.PLoS Genet2011
20332278Assessment of automated image analysis of breast cancer tissue microarrays for epidemiologic studies.Cancer Epidemiol Biomarkers Prev2010
20332278Assessment of automated image analysis of breast cancer tissue microarrays for epidemiologic studies.Cancer Epidemiol Biomarkers Prev2010
18252785Insulinoma and gastrinoma syndromes from a single intrapancreatic neuroendocrine tumor.J Clin Endocrinol Metab2008
18252785Insulinoma and gastrinoma syndromes from a single intrapancreatic neuroendocrine tumor.J Clin Endocrinol Metab2008
18691939Products of anti-CD3/anti-CD28 activated lymphocytes induce differentiation and maturation of dendritic cells and have adjuvant-like activity in vitro and in vivo.Clin Immunol2008
18691939Products of anti-CD3/anti-CD28 activated lymphocytes induce differentiation and maturation of dendritic cells and have adjuvant-like activity in vitro and in vivo.Clin Immunol2008
15832296Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells.Eur J Immunol2005
15832296Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells.Eur J Immunol2005
12759419IL-23 production by cosecretion of endogenous p19 and transgenic p40 in keratin 14/p40 transgenic mice: evidence for enhanced cutaneous immunity.J Immunol2003
12633869Nucleoporation of dendritic cells: efficient gene transfer by electroporation into human monocyte-derived dendritic cells.FEBS Lett2003
12832450Activation by prion peptide PrP106-126 induces a NF-kappaB-driven proinflammatory response in human monocyte-derived dendritic cells.J Leukoc Biol2003
12706410Interaction of papillomavirus virus-like particles with human myeloid antigen-presenting cells.Clin Immunol2003
  • 1 - 50 of 70

Recommended Authors

Massachusetts Institute of Technology
Career Start Year 2013
Number of shared co-authors 0
University of Virginia
Career Start Year 2002
Number of shared co-authors 0
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2002
Number of shared co-authors 0
The University of Texas at Austin
Career Start Year 2000
Number of shared co-authors 0
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 2000
Number of shared co-authors 0
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 6
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 0
University of California San Diego
Career Start Year 1994
Number of shared co-authors 0
Center for Cellular Engineering, National Institutes of Health Clinical Center
Career Start Year 1993
Number of shared co-authors 1
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 1993
Number of shared co-authors 0
Frederick National Laboratory for Cancer Research
Career Start Year 1991
Number of shared co-authors 10
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 2
deCODE genetics/Amgen Inc.
Career Start Year 1988
Number of shared co-authors 18
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 1985
Number of shared co-authors 1
University of Vienna
Career Start Year 1985
Number of shared co-authors 0
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 1
University of Pittsburgh
Career Start Year 1982
Number of shared co-authors 1
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Career Start Year 1981
Number of shared co-authors 0
Center for Computational and Integrative Biology, Massachusetts General Hospital
Career Start Year 1980
Number of shared co-authors 0
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Career Start Year 1980
Number of shared co-authors 0
St. Anna Children's Hospital, Medical University of Vienna
Career Start Year 1980
Number of shared co-authors 0
8Benaroya Research Institute
Career Start Year 1978
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1978
Number of shared co-authors 1
Boston Children's Hospital
Career Start Year 1978
Number of shared co-authors 1
Purdue University
Career Start Year 1978
Number of shared co-authors 1
Lund University
Career Start Year 1977
Number of shared co-authors 2
Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Career Start Year 1975
Number of shared co-authors 0
The Wistar Institute
Career Start Year 1975
Number of shared co-authors 0
A. Menarini Biomarkers Singapore Pte Ltd
Career Start Year 1973
Number of shared co-authors 0

Collaborators

Center for Cancer Research, National Cancer Institute
Co-authored papers 11
National Cancer Institute.
Co-authored papers 7
National Cancer Institute
Co-authored papers 7
Co-authored papers 6
National Cancer Institute, National Institutes of Health
Co-authored papers 5
Spanish National Cancer Research Centre
Co-authored papers 4
David Geffen School of Medicine at university of california los angeles
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Mayo Clinic
Co-authored papers 4
The Usher Institute, The University of Edinburgh
Co-authored papers 4
Co-authored papers 3
University of Calgary, Cumming School of Medicine
Co-authored papers 3
National Cancer Institute
Co-authored papers 3
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Spanish National Cancer Research Centre-CNIO
Co-authored papers 2
Harvard T. H. Chan School of Public Health
Co-authored papers 2
University of Hawaii Cancer Center
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Harvard T.H. Chan School of Public Health
Co-authored papers 2
Case Western Reserve University
Co-authored papers 2
Illumina Inc.
Co-authored papers 2
The Kolling Institute, University of Sydney, and Royal North Shore Hospital
Co-authored papers 2
National Cancer Institute, National Institutes of Health
Co-authored papers 2
National Cancer Institute
Co-authored papers 2
Co-authored papers 2
Arkansas Children's Research Institute
Co-authored papers 2
University of Southern California
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2